 [453][454][455] 
Osteopetrosis is an inherited skeletal disease in which defective bone resorption by osteoclasts leads to excessive bone deposition.' The disease occurs in two basic forms: a relatively mild autosomal dominant adult form, and a more severe autosomal recessive infant form. Infantile malignant osteopetrosis is characterised by increased skeletal mass, extramedullary haemopoiesis, obstruction of the cranial foramina leading to increased intracranial pressure, optic atrophy, blindness, and other neurosensory defects. The probability of a child with infantile malignant osteopetrosis surviving to 6 years of age is about 30%, and most untreated children die within the first decade. ' The only currently effective long term treatment of infantile malignant osteopetrosis is allogeneic bone marrow transplantation (BMT).2 3 In one series, six out of nine children receiving HLA identical BMT exhibited disease-free survival, but age was an important factor in prognosis. In this paper we report on the successful correction of infantile malignant osteopetrosis in the daughter of consanguineous Asian parents by allogeneic BMT from a cousin donor.
Methods
Blood from the patient and relatives was obtained in preservative-free heparin. Viable lymphocytes were separated by standard methods. Genomic DNA for molecular analysis was extracted from fresh or frozen blood samples, or from lymphoid cell lines. Serological HLA typing was carried out by the National Institutes of Health microlymphocytotoxicity technique. Lymphoid cell lines were prepared by immortalising lymphocytes using the B95-8 strain of Epstein-Barr virus. 4 Mixed lymphocyte cultures were carried out as previously described. 5 HLA class II alleles were typed by restriction fragment length polymorphism analysis. [3] [4] [5] [6] [7] [8] (1) and 4-S (2) years after BMT, compared with the proband before transplantation and the donor. Note the presence of bands in both of the samples from the proband after BMT, which are present in the donor, but absent from the sample taken before BMT. blood film, and radiographic appearances are also normal.
Retrospective HI-A molecular typing showed that the patient (before BMT) and donor were identical for DRB1, DQA1, and DQB 1, but mismatched for one DPB1 allele. Before BMT the girl was homozygous for DPB1*0401, and her donor cousin (VII. 
Discussion
We describe the successful correction of infantile osteopetrosis in an Asian child by BMT using a cousin donor. An extensive family search for a matched donor was instigated because evidence of consanguinity suggested restricted HIA heterogeneity. Bone marrow from the HLA compatible cousin donor fully corrected the osteopetrosis, and the patient remains in good health eight years after transplant. The weak mixed lymphocyte culture reaction between the patient and donor in the HvG direction before transplantation was found to be due to DPB 1 incompatibility. Long term engraftment is evident from the results of SSCP analysis of the patient four years after BMT, and the absence of GvH disease indicates that the DPB 1 mismatch presented no significant clinical problem.
The presence of significant numbers of Asian immigrants in this region practising first cousin marriage9 may be a factor in the frequency of osteopetrosis. One of the most important criteria for the success of BMT in infantile malignant osteopetrosis is early diagnosis and identification of a suitably matched donor.' As an HLA matched sibling donor may not be available, and the results of cross racial unrelated donor transplants are poor, the only realistic option is to search for a matched donor in the extended family. The limited genetic heterogeneity in some Asian families significantly increases the chance of finding an HLA matched donor.
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